Publications

Found 1 results
Filters: Author is H. Yun  [Clear All Filters]
2010
L. Gao, Wang, L., Yun, H., Su, L., and Su, X., Association of the PPARγ2 gene Pro12Ala variant with primary hypertension and metabolic lipid disorders in Han Chinese of Inner Mongolia, vol. 9, pp. 1312-1320, 2010.
Ahmed W, Ziouzenkova O, Brown J, Devchand P, et al. (2007). PPARs and their metabolic modulation: new mechanisms for transcriptional regulation? J. Intern. Med. 262: 184-198. http://dx.doi.org/10.1111/j.1365-2796.2007.01825.x PMid:17645586   Buzzetti R, Petrone A, Caiazzo AM, Alemanno I, et al. (2005). PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity. Pediatr. Res. 57: 138-140. http://dx.doi.org/10.1203/01.PDR.0000147728.62185.21 PMid:15531738   Douglas JA, Erdos MR, Watanabe RM, Braun A, et al. (2001). The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences. Diabetes 50: 886-890. http://dx.doi.org/10.2337/diabetes.50.4.886 PMid:11289057   Ereqat S, Nasereddin A, Azmi K, Abdeen Z, et al. (2009). Impact of the Pro12Ala polymorphism of the PPAR-gamma 2 gene on metabolic and clinical characteristics in the Palestinian type 2 diabetic patients. PPAR Res. 2009: 874126. http://dx.doi.org/10.1155/2009/874126 PMid:19859551 PMCid:2766506   Gouni-Berthold I, Giannakidou E, Muller-Wieland D, Faust M, et al. (2005). Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2. J. Hypertens. 23: 301-308. http://dx.doi.org/10.1097/00004872-200502000-00012 PMid:15662218   Greene ME, Blumberg B, McBride OW, Yi HF, et al. (1995). Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr. 4: 281-299. PMid:7787419   Hasstedt SJ, Ren QF, Teng K and Elbein SC (2001). Effect of the peroxisome proliferator-activated receptor-gamma 2 pro(12)ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds. J. Clin. Endocrinol. Metab. 86: 536-541. http://dx.doi.org/10.1210/jc.86.2.536 PMid:11158005   He W (2009). PPARgamma2 polymorphism and human health. PPAR. Res. 2009: 849538. http://dx.doi.org/10.1155/2009/849538 PMid:19390629 PMCid:2669649   Horiki M, Ikegami H, Fujisawa T, Kawabata Y, et al. (2004). Association of Pro12Ala polymorphism of PPARgamma gene with insulin resistance and related diseases. Diabetes Res. Clin. Pract. 66 (Suppl 1): S63-S67. http://dx.doi.org/10.1016/j.diabres.2003.09.023 PMid:15563983   Mirzaei H, Akrami SM, Golmohammadi T, Doosti M, et al. (2009). Polymorphism of Pro12Ala in the peroxisome proliferator-activated receptor gamma2 gene in Iranian diabetic and obese subjects. Metab. Syndr. Relat. Disord. 7: 453-458. http://dx.doi.org/10.1089/met.2008.0099 PMid:19558269   Ostgren CJ, Lindblad U, Melander O, Melander A, et al. (2003). Peroxisome proliferator-activated receptor-gammaPro12Ala polymorphism and the association with blood pressure in type 2 diabetes: Skaraborg Hypertension and Diabetes Project. J. Hypertens. 21: 1657-1662.   Pinterova D, Cerna M, Kolostova K, Novota P, et al. (2004). The frequency of alleles of the Pro12Ala polymorphism in PPARgamma2 is different between healthy controls and patients with type 2 diabetes. Folia Biol. 50: 153-156.   Rodriguez-Esparragon FJ, Rodriguez-Perez JC, Macias-Reyes A and Alamo-Santana F (2003). Peroxisome proliferator-activated receptor-gamma2-Pro12Ala and endothelial nitric oxide synthase-4a/bgene polymorphisms are associated with essential hypertension. J. Hypertens. 21: 1649-1655. http://dx.doi.org/10.1097/00004872-200309000-00013 PMid:12923396   Sookoian S, Garcia SI, Porto PI, Dieuzeide G, et al. (2005). Peroxisome proliferator-activated receptor gamma and its coactivator-1 alpha may be associated with features of the metabolic syndrome in adolescents. J. Mol. Endocrinol. 35: 373-380. http://dx.doi.org/10.1677/jme.1.01837 PMid:16216916   Stefanski A, Majkowska L, Ciechanowicz A, Frankow M, et al. (2006). Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes. J. Hum. Hypertens. 20: 684-692. http://dx.doi.org/10.1038/sj.jhh.1002040 PMid:16625233   Swarbrick MM, Chapman CM, McQuillan BM, Hung J, et al. (2001). A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity. Eur. J. Endocrinol. 144: 277-282. http://dx.doi.org/10.1530/eje.0.1440277 PMid:11248748   Tai ES, Corella D, Deurenberg-Yap M, Adiconis X, et al. (2004). Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population. J. Lipid Res. 45: 674-685. http://dx.doi.org/10.1194/jlr.M300363-JLR200 PMid:14729856   Tamori Y, Masugi J, Nishino N and Kasuga M (2002). Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes 51: 2045-2055. http://dx.doi.org/10.2337/diabetes.51.7.2045 PMid:12086932   Tavares V, Hirata RD, Rodrigues AC, Monte O, et al. (2005). Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus. Diabetes Obes. Metab. 7: 605-611. http://dx.doi.org/10.1111/j.1463-1326.2004.00453.x PMid:16050954   Vanden Heuvel JP (2007). The PPAR resource page. Biochim. Biophys. Acta 1771: 1108-1112. http://dx.doi.org/10.1016/j.bbalip.2007.03.007 PMid:17493868   Yliharsila H, Eriksson JG, Forsen T, Laakso M, et al. (2004). Interactions between peroxisome proliferator-activated receptor-gamma 2 gene polymorphisms and size at birth on blood pressure and the use of antihypertensive medication. J. Hypertens. 22: 1283-1287. http://dx.doi.org/10.1097/01.hjh.0000125438.28861.a4 PMid:15201543   Zietz B, Barth N, Spiegel D, Schmitz G, et al. (2002). Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male Caucasian type 2 diabetes patients. Exp. Clin. Endocrinol. Diabetes 110: 60-66. http://dx.doi.org/10.1055/s-2002-23487 PMid:11928067